MoneyWorks4Me

The sales slipped to Rs. 5382.10 millions for the December 2023 quarter as against Rs. 6255.30 millions during the year-ago period.Net profit declined -13.87% to Rs. 316.20 millions from Rs. 367.10 millions.Operating profit for the quarter ended December 2023 decreased to 614.20 millions as compared to 699.50 millions of corresponding quarter ended December 2022.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202312 202212 % Var 202312 202212 % Var 202303 202203 % Var
Sales 5382.10 6255.30 -13.96 17073.80 18015.60 -5.23 24979.70 22511.70 10.96
Other Income 16.80 9.70 73.20 30.70 13.00 136.15 22.30 47.80 -53.35
PBIDT 614.20 699.50 -12.19 2001.40 1951.90 2.54 2846.30 3229.50 -11.87
Interest 67.50 91.20 -25.99 220.70 241.80 -8.73 325.30 200.60 62.16
PBDT 546.70 608.30 -10.13 1780.70 1710.10 4.13 2521.00 3028.90 -16.77
Depreciation 118.00 118.70 -0.59 353.30 356.20 -0.81 472.90 473.90 -0.21
PBT 428.70 489.60 -12.44 1427.40 1353.90 5.43 2048.10 2555.00 -19.84
TAX 112.50 122.50 -8.16 370.00 357.50 3.50 520.00 605.00 -14.05
Deferred Tax 5.00 -12.50 -140.00 25.00 2.50 900.00 -12.50 -50.00 -75.00
PAT 316.20 367.10 -13.87 1057.40 996.40 6.12 1528.10 1950.00 -21.64
Equity 919.40 926.00 -0.71 926.00 926.00 0.00 926.00 926.00 0.00
PBIDTM(%) 11.41 11.18 2.05 11.72 10.83 8.19 11.39 14.35 -20.57
Peers
Company Name CMP
Sun Pharma. Inds. 1866.00
Dr. Reddys Labs. 1172.05
Cipla 1372.25
Lupin 2092.00
Zydus Lifesciences 1137.35
View more..